Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

11,322 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Brain masculinization requires androgen receptor function.
Sato T, Matsumoto T, Kawano H, Watanabe T, Uematsu Y, Sekine K, Fukuda T, Aihara K, Krust A, Yamada T, Nakamichi Y, Yamamoto Y, Nakamura T, Yoshimura K, Yoshizawa T, Metzger D, Chambon P, Kato S. Sato T, et al. Among authors: yamada t. Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1673-8. doi: 10.1073/pnas.0305303101. Epub 2004 Jan 27. Proc Natl Acad Sci U S A. 2004. PMID: 14747651 Free PMC article.
Suppressive function of androgen receptor in bone resorption.
Kawano H, Sato T, Yamada T, Matsumoto T, Sekine K, Watanabe T, Nakamura T, Fukuda T, Yoshimura K, Yoshizawa T, Aihara K, Yamamoto Y, Nakamichi Y, Metzger D, Chambon P, Nakamura K, Kawaguchi H, Kato S. Kawano H, et al. Among authors: yamada t. Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9416-21. doi: 10.1073/pnas.1533500100. Epub 2003 Jul 18. Proc Natl Acad Sci U S A. 2003. PMID: 12872002 Free PMC article.
Chondromodulin I is a bone remodeling factor.
Nakamichi Y, Shukunami C, Yamada T, Aihara K, Kawano H, Sato T, Nishizaki Y, Yamamoto Y, Shindo M, Yoshimura K, Nakamura T, Takahashi N, Kawaguchi H, Hiraki Y, Kato S. Nakamichi Y, et al. Among authors: yamada t. Mol Cell Biol. 2003 Jan;23(2):636-44. doi: 10.1128/MCB.23.2.636-644.2003. Mol Cell Biol. 2003. PMID: 12509461 Free PMC article.
Phase III study of ranimustine, cyclophosphamide, vincristine, melphalan, and prednisolone (MCNU-COP/MP) versus modified COP/MP in multiple myeloma: a Japan clinical oncology group study, JCOG 9301.
Takenaka T, Itoh K, Suzuki T, Utsunomiya A, Matsuda S, Chou T, Sai T, Sano M, Konda S, Ohno T, Mikuni C, Deura K, Yamada T, Mizorogi F, Nagoshi H, Tomonaga M, Hotta T, Kawano K, Tsushita K, Hirano M, Shimoyama M; Lymphoma Study Group of the Japan Clinical Oncology Group. Takenaka T, et al. Among authors: yamada t. Int J Hematol. 2004 Feb;79(2):165-73. doi: 10.1532/ijh97.03115. Int J Hematol. 2004. PMID: 15005346 Clinical Trial.
11,322 results
You have reached the last available page of results. Please see the User Guide for more information.